PDip (BioInnovation)

University of Galway

BioInnovate Ireland is a national health technology innovation programme based at the University of Galway. The programme is a global affiliate of the University of Stanford Biodesign methodology and leverages this approach to provide a talented multidisciplinary pool of innovators the opportunity to develop novel medical innovations and shape the future of healthcare globally. The programme operates in partnership with a host of national and international partners including Stanford University, American College of Cardiology, our EIT Health funded European Fellowship Network, University College Cork, Trinity College Dublin, Mayo Clinic, Boston Scientific, Medtronic, Abbott Vascular, Creganna, and Aerogen.The programme applies needs led innovation and entrepreneurship to real world healthcare problems. This unique approach allows the identification and validation of unmet clinical needs with an associated market opportunity and facilitates the development and commercial de-risking of emerging technologies in the Medtech sector. The goal of the programme is to educate BioInnovate Ireland Fellows and Industry Trainees with a view to developing the next generation of medtech leaders, embedding design capabilities in Irish companies and driving the creation of new Irish start-ups.Career OpportunitiesAll of our graduates are currently employed with approximately half of them pursuing commercial opportunities identified during the programme. Several graduates work in start-ups, major multinationals or the government sector.

College of Science and Engineering